<p>Treace Medical Concepts Inc. 宣布与 SLR Capital Partners 管理的信贷基金达成一项新的五年期、1.75 亿美元的高级担保贷款协议。该融资方案包括在交割时提供的 6000 万美元的定期贷款、额外的 6500 万美元定期贷款可用额度，以及 5000 万美元的循环信贷额度，所有这些均需满足特定条件。新定期贷款的收益用于偿还公司之前的 5000 万美元定期贷款和 400 万美元的前循环信贷额度。该安排旨在增强 Treace Medical 的资产负债表，提高财务灵活性，并支持公司在手术治疗拇外翻及相关中足畸形方面的商业策略。免责声明：本新闻简报由公共技术公司（PUBT）使用生成性人工智能创建。虽然 PUBT 努力提供准确和及时的信息，但此 AI 生成的内容仅供参考，不应被解读为财务、投资或法律建议。Treace Medical Concepts Inc. 于 2025 年 12 月 18 日通过 GlobeNewswire 发布了用于生成本新闻简报的原始内容（参考 ID：GNW9604133-en），并对此信息的内容承担全部责任。© 版权 2025 - 公共技术公司（PUBT）</p>

TMCI

<p>Treace Medical Concepts Inc. 已从 SLR Capital Partners 获得一笔 1.75 亿美元的五年期高级担保贷款，以增强其财务灵活性并支持在拇外翻和中足畸形治疗方面的商业策略。该融资包括定期贷款和循环信贷额度，旨在加强公司的资产负债表。这笔资金将用于偿还之前的贷款并支持增长计划</p>

<p>Treace Medical Concepts Inc. has announced a new five-year, $175 million senior secured loan agreement with credit funds managed by SLR Capital Partners. The financing package includes $60 million in term loans funded at closing, an additional $65 million in term loan availability, and a $50 million revolving credit facility, all subject to certain conditions. Proceeds from the new term loan were used to repay the company’s previous $50 million term loan and $4 million drawn under its former revolving credit facility. The arrangement is designed to strengthen Treace Medical’s balance sheet, enhance financial flexibility, and support the company’s commercial strategies in the surgical treatment of bunions and related midfoot deformities. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Treace Medical Concepts Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9604133-en) on December 18, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>
<div class="lb-trans"><p>Treace Medical Concepts Inc. 宣布与 SLR Capital Partners 管理的信贷基金达成一项新的五年期、1.75 亿美元的高级担保贷款协议。该融资方案包括在交割时提供的 6000 万美元的定期贷款、额外的 6500 万美元定期贷款可用额度，以及 5000 万美元的循环信贷额度，所有这些均需满足特定条件。新定期贷款的收益用于偿还公司之前的 5000 万美元定期贷款和 400 万美元的前循环信贷额度。该安排旨在增强 Treace Medical 的资产负债表，提高财务灵活性，并支持公司在手术治疗拇外翻及相关中足畸形方面的商业策略。免责声明：本新闻简报由公共技术公司（PUBT）使用生成性人工智能创建。虽然 PUBT 努力提供准确和及时的信息，但此 AI 生成的内容仅供参考，不应被解读为财务、投资或法律建议。Treace Medical Concepts Inc. 于 2025 年 12 月 18 日通过 GlobeNewswire 发布了用于生成本新闻简报的原始内容（参考 ID：GNW9604133-en），并对此信息的内容承担全部责任。© 版权 2025 - 公共技术公司（PUBT）</p>
</div>

Treace Medical 获得 1.75 亿美元的五年期债务融资以推动增长